Department of Surgery, Graduate School of Biomedical Sciences, Hiroshima University Hospital, Hiroshima University, Hiroshima, Japan.
Cancer Sci. 2011 Feb;102(2):330-5. doi: 10.1111/j.1349-7006.2010.01786.x. Epub 2010 Nov 26.
Our previous report demonstrated a good correlation between high telomerase activity of cancer tissues and a poor prognosis of patients with colorectal cancers, except for several cases. To elucidate the additional factors that contribute to patient prognosis, the correlation among the expression levels of telomere binding proteins (TBP), the lengths of telomeres, the lengths of telomere 3'-overhang (3'-OH) and telomerase activity in 106 paired colorectal cancer and corresponding noncancerous mucosa (NCM) specimens were examined. The expression levels of eight TBP genes (TRF1, TRF2, TIN2, TANK1, TANK2, POT1, RAP1 and TPP1) were analyzed. Among the 106 cases, 35 cases had shortened telomeres (<7 kb), 15 had shortened 3'-OH (3'-OH length ratio of cancer/NCM <0.5) and 88 were classified as telomerase-activated cancers (activity ratio of cancer/NCM >2). Comparison between NCM and cancer in each case showed that all TBP except for POT1 were downregulated in cancers. A survival analysis using a Cox proportional hazard model showed that the survival rate of the telomerase-activated cases with shortened 3'-OH and that of telomerase-inactivated cases were significantly better than that of telomerase-activated cases without 3'-OH shortening, that is, restored or maintained 3'-OH (P = 0.018). In the telomerase-activated cancers, the length of 3'-OH was significantly correlated with the expression levels of POT1. Elongation of telomeric overhang by telomerase, which might be regulated by POT1, may contribute to the increase of malignant potential in colorectal cancers.
我们之前的报告表明,结直肠癌组织中端粒酶活性高与患者预后不良之间存在良好的相关性,但也有少数例外。为了阐明导致患者预后不良的其他因素,我们研究了 106 对结直肠癌和相应的非癌黏膜(NCM)标本中端粒结合蛋白(TBP)的表达水平、端粒长度、端粒 3'-突出(3'-OH)长度和端粒酶活性之间的相关性。分析了 8 个 TBP 基因(TRF1、TRF2、TIN2、TANK1、TANK2、POT1、RAP1 和 TPP1)的表达水平。在这 106 例病例中,35 例端粒缩短(<7 kb),15 例 3'-OH 缩短(癌症/NCM 的 3'-OH 长度比<0.5),88 例被归类为端粒酶激活型癌症(癌症/NCM 的活性比>2)。在每个病例中比较 NCM 和癌症时,除了 POT1 之外,所有 TBP 在癌症中都下调。使用 Cox 比例风险模型的生存分析显示,3'-OH 缩短的端粒酶激活病例和端粒酶失活病例的存活率明显优于没有 3'-OH 缩短的端粒酶激活病例,即恢复或维持 3'-OH(P = 0.018)。在端粒酶激活型癌症中,3'-OH 的长度与 POT1 的表达水平显著相关。端粒酶延长端粒突出,可能受 POT1 调控,可能有助于增加结直肠癌的恶性潜能。